Autopsy report · NCT02317263

A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis

“NIH did not fund the study so it never started”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of California, Los Angeles

Sponsor type

University, hospital or other

Conditions

Multiple Sclerosis

Interventions

testosterone; placebo gel

Participants

0

Trials that died the same way

• Improvements in Cognitive Skills of Older Adults Using Dynamic Visual Attention Training
  “Study was never funded by NIH as anticipated.” (74% match in meaning)
• Angiotensin 2 for Hepatorenal Syndrome
  “Funding issues; the study was never started” (71% match in meaning)
• Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19
  “The study did not get financed. Never got started.” (70% match in meaning)
• Adenomyosis: Genomic Mechanisms and Biological Response
  “The study never got funded so never started enrolling” (70% match in meaning)
• GO-203-2C + Bortezomib For Relapsed Or Refractory MM
  “Study was never open due to lack of funding” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.